ID22037A - PROSES REKOMBINAN UNTUK MEMBUAT ANTIGEN MALARIA KOMPLET gp190/MSPI - Google Patents

PROSES REKOMBINAN UNTUK MEMBUAT ANTIGEN MALARIA KOMPLET gp190/MSPI

Info

Publication number
ID22037A
ID22037A IDW990194A ID990194A ID22037A ID 22037 A ID22037 A ID 22037A ID W990194 A IDW990194 A ID W990194A ID 990194 A ID990194 A ID 990194A ID 22037 A ID22037 A ID 22037A
Authority
ID
Indonesia
Prior art keywords
antigenal
mspi
complet
malaria
making
Prior art date
Application number
IDW990194A
Other languages
English (en)
Indonesian (id)
Inventor
Hermann Bujard
Ralf Tolle
Weiqing Pan
Original Assignee
Hermann Bujard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hermann Bujard filed Critical Hermann Bujard
Publication of ID22037A publication Critical patent/ID22037A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IDW990194A 1996-10-02 1997-10-02 PROSES REKOMBINAN UNTUK MEMBUAT ANTIGEN MALARIA KOMPLET gp190/MSPI ID22037A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19640817A DE19640817A1 (de) 1996-10-02 1996-10-02 Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1

Publications (1)

Publication Number Publication Date
ID22037A true ID22037A (id) 1999-08-26

Family

ID=7807776

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW990194A ID22037A (id) 1996-10-02 1997-10-02 PROSES REKOMBINAN UNTUK MEMBUAT ANTIGEN MALARIA KOMPLET gp190/MSPI

Country Status (11)

Country Link
US (2) US6933130B1 (fr)
EP (2) EP1637602A1 (fr)
JP (1) JP2000516477A (fr)
CN (1) CN1148448C (fr)
AT (1) ATE299939T1 (fr)
AU (1) AU727864B2 (fr)
DE (2) DE19640817A1 (fr)
DK (1) DK0929677T3 (fr)
ES (1) ES2244993T3 (fr)
ID (1) ID22037A (fr)
WO (1) WO1998014583A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1025244A2 (fr) 1997-10-20 2000-08-09 Genzyme Transgenics Corporation SEQUENCES D'ACIDES NUCLEIQUES MSP-1 MODIFIES ET PROCEDES PERMETTANT D'ACCROITRE LES NIVEAUX D'ARNm ET L'EXPRESSION DES PROTEINES DANS LES SYSTEMES CELLULAIRES
WO2001066776A2 (fr) * 2000-03-10 2001-09-13 Institut für Molekulare Biotechnologie E.V. Nouvelle souche bacterienne de forme l, leur procede de production et leur utilisation pour la production de produits geniques
CN1176945C (zh) * 2001-02-01 2004-11-24 中国人民解放军第二军医大学 疟原虫融合抗原及其制法和用途
EP1490494A1 (fr) * 2002-04-01 2004-12-29 Walter Reed Army Institute of Research Procede pour concevoir des sequences d'acides nucleiques de synthese pour l'expression optimale de proteines dans une cellule hote
DE10249390A1 (de) * 2002-10-23 2004-05-13 Ruprecht-Karls-Universität Heidelberg Rekombinante MVA-Stämme als potentielle Impfstoffe gegen P.falciparum-Malaria
JP4315907B2 (ja) 2002-11-22 2009-08-19 エーザイ・アール・アンド・ディー・マネジメント株式会社 マラリア原虫のｇｐｉの生合成を阻害する化合物をスクリーニングする方法
EP1649869A1 (fr) * 2004-10-21 2006-04-26 Vakzine Projekt Management GmbH Combinaison d'une mycobacterie et d'un agent biologiquement actif comme vaccin
AU2007249695A1 (en) * 2006-05-15 2007-11-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008059314A1 (fr) * 2006-11-14 2008-05-22 Centro Internacional De Vacunas Vaccin antipaludique fondé sur la sous-unité 200l de la protéine msp1 de plasmodium vivax
EP1944313A1 (fr) * 2007-01-15 2008-07-16 Vakzine Projekt Management GmbH Vaccin contre la malaria recombinant
EP2141177A1 (fr) 2008-07-04 2010-01-06 Bujard, Hermann Préparations de protéine MSP-1 à partir de Plasmodium
US8501926B2 (en) * 2008-09-24 2013-08-06 The Johns Hopkins University Malaria vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0154454B1 (fr) * 1984-02-22 1991-07-03 The Wellcome Foundation Limited Clonage d'ADN pour antigènes protozoiques
US4978621A (en) * 1985-09-03 1990-12-18 Scripps Clinic And Research Foundation Merozoite surface antigens
WO1988000595A1 (fr) * 1986-07-17 1988-01-28 Saramane Pty. Ltd. Antigene de plasmodium falciparum apparaissant a la surface de merozoites
US4897354A (en) * 1986-07-28 1990-01-30 University Of Hawaii Monoclonal antibody-specific merozoite antigens
GB8810808D0 (en) * 1988-05-06 1988-06-08 Wellcome Found Vectors
NZ230375A (en) * 1988-09-09 1991-07-26 Lubrizol Genetics Inc Synthetic gene encoding b. thuringiensis insecticidal protein
AU638438B2 (en) * 1989-02-24 1993-07-01 Monsanto Technology Llc Synthetic plant genes and method for preparation
US5766597A (en) * 1991-03-07 1998-06-16 Virogenetics Corporation Malaria recombinant poxviruses
AU674491B2 (en) * 1991-03-20 1997-01-02 Virogenetics Corporation Recombinant poxvirus malaria vaccine

Also Published As

Publication number Publication date
DK0929677T3 (da) 2005-11-14
ATE299939T1 (de) 2005-08-15
JP2000516477A (ja) 2000-12-12
EP0929677A2 (fr) 1999-07-21
ES2244993T3 (es) 2005-12-16
DE19640817A1 (de) 1998-05-14
CN1236391A (zh) 1999-11-24
AU727864B2 (en) 2001-01-04
AU4864997A (en) 1998-04-24
CN1148448C (zh) 2004-05-05
DE59712370D1 (de) 2005-08-25
EP1637602A1 (fr) 2006-03-22
US6933130B1 (en) 2005-08-23
US20050095256A1 (en) 2005-05-05
WO1998014583A2 (fr) 1998-04-09
EP0929677B1 (fr) 2005-07-20

Similar Documents

Publication Publication Date Title
AU659330B2 (en) RNA catalyst for cleaving specific RNA sequences
EP0804609A4 (fr) NOUVEAUX GENES DE REPONSE p53
NO331104B1 (no) Isolert nukleinsyremolekyl, vektor, vertscelle, fremgangsmate, isolert polypeptid, preparat og anvendelse.
WO2001062794A3 (fr) Nouveaux canaux calciques humains 18607
ID22037A (id) PROSES REKOMBINAN UNTUK MEMBUAT ANTIGEN MALARIA KOMPLET gp190/MSPI
WO2001072976A3 (fr) 32142, 21481, 25964, 21686, nouvelles molecules deshydrogenases humaines et utilisations
EP1798239A3 (fr) Récepteurs de protéine G-couplés et utilisations correspondantes
WO2002000722A3 (fr) 48000 et 52920, nouveaux canaux calciques humains et leurs utilisations
WO1993017031A3 (fr) Acides nucleiques codant des proteines associees a la dystrophine
ATE377087T1 (de) Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors
DE69031803D1 (de) Verfahren und nukleinsäuresequenzen zur expression des zellulose-synthase-operons
WO2001092493A3 (fr) Nouvelles aminopeptidases humaines 21956 et 25856, et utilisations
EE03074B1 (et) Rekombinantsed eukarüootsed rakud, nende saamiseks vajalikud DNA järjestused, meetod eukarüootsete rakkude konstrueerimiseks ja sekreteeritavate valkude ning biomassi tootmismeetod
WO2002074960A3 (fr) Methodes et compositions relatives aux proteines humaines 38650, 28472, 5495, 65507, 81588 et 14354 et leurs utilisations
WO2001064904A3 (fr) Membres de la famille transferase 25324, 50287, 28899, 47007, et 42967 et utilisations de ces derniers
ZA200007619B (en) New peptide fragments for protein purification.
WO2001066764A3 (fr) 16835, un nouvel element de la famille c de phospholipase humaine et utilisations correspondantes
MXPA01011563A (es) Una novedosa proteina 5 relacionada al factro-h y anticuerpos relacionados.
WO2001090146A3 (fr) Nouveaux transporteurs humains, 57256 et 58289, et utilisations correspondantes
EP1241186A3 (fr) Protéine gas-6 (growth arrest-specific gene 6) humaine et acides nucléiques le codant
WO2002020801A3 (fr) 26199, 33530, 33949, 47148, 50226, et 58764, nouveaux membres de la famille des transferases humaines et utilisations de ceux-ci
EP1683859A3 (fr) Eventuel gène codant pour Catechol 1,2-Dioxygenase de Corynebacterium glutamicum
WO2001079293A3 (fr) 57809 et 57798, nouvelles molecules de cadherine humaines et utilisations
WO2002029037A3 (fr) 57800, nouvelle cadherine humaine et ses applications
WO2002057457A3 (fr) 55562 et 21617, nouvelles proteines humaines et leurs methodes d'utilisation